Monotherapies with either WT1-TCB or Ven/Aza inhibited tumor growth (day 36: 1850 ± 432 mm3 and 1316 ± 213 mm3, respectively), compared to the corresponding vehicle control (2528 ± 468 mm3). This evidence concerns the gene WT1 and neoplasm.